Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
Marc P. Bonaca, Richard T. De George, David A. Morrow, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 3, pp. 243-252
Open Access | Times Cited: 19

Showing 19 citing articles:

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 577
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 238
Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives
Xiuting Xu, Zikai Song, Bao Mao, et al.
Cardiovascular Therapeutics (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 31
HDL maturation and remodelling
Kwok Leung Ong, Blake J. Cochran, Bikash Manandhar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 4, pp. 159119-159119
Closed Access | Times Cited: 21
Lecithin:Cholesterol Acyltransferase Binds a Discontinuous Binding Site on Adjacent Apolipoprotein A-I Belts in HDL
Bethany Coleman, Shimpi Bedi, John H. Hill, et al.
Journal of Lipid Research (2025), pp. 100786-100786
Open Access
Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential
Huiru Tang, Chengxia Kan, Kexin Zhang, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
Richard T. De George, Liron Abuhatzira, Susan M. Stoughton, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 25
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B
Marc P. Bonaca, David A. Morrow, Brian A. Bergmark, et al.
Circulation (2022) Vol. 146, Iss. 12, pp. 907-916
Open Access | Times Cited: 16
Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo
Lita A. Freeman, Robert D. Shamburek, Maureen Sampson, et al.
Journal of Lipid Research (2019) Vol. 60, Iss. 5, pp. 1050-1057
Open Access | Times Cited: 14
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies
Ilaria Zanotti, Francesco Potì, Marina Cuchel
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159065-159065
Closed Access | Times Cited: 11
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans
Gissette Reyes‐Soffer, Anastasiya Matveyenko, James Lignos, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 6, pp. 1407-1418
Closed Access | Times Cited: 1
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase
Akseli Niemelä, Laura Giorgi, Sirine Nouri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 1
The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I
Shane R. Thomas, Yunjia Zhang, Kerry‐Anne Rye
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101689-101689
Closed Access | Times Cited: 7
High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?
Arnold von Eckardstein
Handbook of experimental pharmacology (2021), pp. 157-200
Open Access | Times Cited: 9
Association of Plasma Vitamins and Carotenoids, DNA Methylation of LCAT, and Risk of Age-Related Macular Degeneration
Zhaofang Li, Yajing Li, Yijing Hou, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2985-2985
Open Access | Times Cited: 3
Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis
Cecilia Vitali, Marina Cuchel
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 1, pp. 377-379
Open Access | Times Cited: 7
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma
Lingwang Kong, Miao Liu, Hang Yang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2251-2265
Open Access
Gliflozins, sucrose and flavonoids are allosteric activators of lecithin:cholesterol acyltransferase
Akseli Niemelä, Laura Giorgi, Sirine Nouri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effects of Administration of Recombinant Human Lecithin-Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans
Gissette Reyes‐Soffer, Anastasiya Matveyenko, James Lignos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top